Edition:
United Kingdom

Profile: J B Chemicals and Pharmaceuticals Ltd (JBCH.NS)

JBCH.NS on National Stock Exchange of India

347.30INR
18 Apr 2019
Change (% chg)

Rs-7.40 (-2.09%)
Prev Close
Rs354.70
Open
Rs349.00
Day's High
Rs353.90
Day's Low
Rs344.45
Volume
18,174
Avg. Vol
52,849
52-wk High
Rs373.85
52-wk Low
Rs239.95

J. B. Chemicals & Pharmaceuticals Limited is a pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs). The Company's business segments include domestic formulation business, exports and API business. The Company markets various contrast media products in India, such as Contrapaque (Iohexol), Lek Pamidol (Iopamidol), Trazograf (Diatrazoic acid), Trazogastro - Oral contrast (Diatrazoic acid), Magnilek Injection (Gadopentatic acid) and Cardiolek Injection (Iodixanol). The Company's brands for the Indian pharmaceutical market include Metrogyl (Metronidazole), Nicardia (Nifedipine), Rantac (Ranitidine), Dicloran (Diclofenac Sodium), OF (Ofloxacin), Cilacar (Cilnidipine) and Zecuf herbal. It manufactures generic products for the regulated markets and branded formulations for the emerging markets. It manufactures various APIs, such as Cilnidipine, Diclofenac Acid and Gadopentatic acid.

Company Address

J B Chemicals and Pharmaceuticals Ltd

Neelam Centre, 4th Floor
B Wing, Hind Cycle Road
Worli
MUMBAI     400025
P: +9122.24395200
F: +9122.24930534

Company Web Links